Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 233
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
"Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Active
18 and over
Other
2005-060-version1a
NCT00338481
2.
Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care, Treatment
Active
18 to 75
Other
UMCN-AKF 07.02
EudraCTnr 2007-003347-73, NCT00588835
3.
Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Diagnostic
Approved-not yet active
60 to 80
Other
PROLOG
NCT00675168
4.
Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Approved-not yet active
18 and over
Other
2612-3681
NCT00724581
5.
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Diagnostic
Active
15 and over
Other
SP-11-0035
NCT00123760
6.
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Supportive care, Treatment
Active
18 and over
Other
001-0015-211
NCT00127387
7.
A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Active
18 to 75
Other
Haema CBF SCLC UK/AS 01
NCT00168896
8.
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Biomarker/Laboratory analysis, Tissue collection/Repository
Active
19 and over
NCI, Other
04-109
NCT00132704
9.
18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Diagnostic
Active
19 to 90
Other
R05-0076
NCT00207298
Last Modified:
5/22/2008
 
First Published:
8/24/2006
10.
Phase III Randomized Study of Printed Psychoeducational Interventions in Patients Completing Active Treatment For Stage I-IIIA Breast, Colorectal, Prostate, or Thoracic Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Educational/Counseling/Training, Supportive care
Active
18 and over
NCI
FCCC-FCRB-04-002-P
NCT00372840
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute